NO902251D0 - Fremstilling av gonorrheiske p1-proteiner og vaksiner. - Google Patents

Fremstilling av gonorrheiske p1-proteiner og vaksiner.

Info

Publication number
NO902251D0
NO902251D0 NO1990902251A NO902251A NO902251D0 NO 902251 D0 NO902251 D0 NO 902251D0 NO 1990902251 A NO1990902251 A NO 1990902251A NO 902251 A NO902251 A NO 902251A NO 902251 D0 NO902251 D0 NO 902251D0
Authority
NO
Norway
Prior art keywords
full length
protein
gonorrheis
vaccines
proteins
Prior art date
Application number
NO1990902251A
Other languages
English (en)
Other versions
NO902251L (no
NO302622B1 (no
Inventor
Nicholas H Carbonetti
Frederick P Sparling
Original Assignee
Univ North Carolina
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ North Carolina filed Critical Univ North Carolina
Publication of NO902251D0 publication Critical patent/NO902251D0/no
Publication of NO902251L publication Critical patent/NO902251L/no
Publication of NO302622B1 publication Critical patent/NO302622B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/22—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Neisseriaceae (F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/095—Neisseria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
NO902251A 1987-11-24 1990-05-22 Rekombinant vektor, vertsorganisme, fremgangsmåte for fremstilling av et fullengde PIA protein fra Neisseria gonorrhoeae NO302622B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US12472787A 1987-11-24 1987-11-24
US24275888A 1988-09-09 1988-09-09
PCT/US1988/004225 WO1989004873A1 (en) 1987-11-24 1988-11-23 Production of gonorrheal pi proteins and vaccines

Publications (3)

Publication Number Publication Date
NO902251D0 true NO902251D0 (no) 1990-05-22
NO902251L NO902251L (no) 1990-07-18
NO302622B1 NO302622B1 (no) 1998-03-30

Family

ID=26822891

Family Applications (1)

Application Number Title Priority Date Filing Date
NO902251A NO302622B1 (no) 1987-11-24 1990-05-22 Rekombinant vektor, vertsorganisme, fremgangsmåte for fremstilling av et fullengde PIA protein fra Neisseria gonorrhoeae

Country Status (12)

Country Link
US (2) US5736361A (no)
EP (2) EP0395706B1 (no)
JP (2) JP2803058B2 (no)
KR (1) KR970011309B1 (no)
AT (1) ATE169958T1 (no)
AU (1) AU629807B2 (no)
CA (1) CA1340506C (no)
DE (1) DE3856240T2 (no)
DK (1) DK175831B1 (no)
FI (1) FI102189B (no)
NO (1) NO302622B1 (no)
WO (1) WO1989004873A1 (no)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1340506C (en) * 1987-11-24 1999-04-20 Nicholas H. Carbonetti Production of gonorrheal pi proteins and vaccines
US7118757B1 (en) * 1988-12-19 2006-10-10 Wyeth Holdings Corporation Meningococcal class 1 outer-membrane protein vaccine
CA2105382C (en) * 1991-03-14 1999-01-19 Neil Goldstein Recombinant hybrid porin epitopes
AU7408494A (en) * 1993-07-30 1995-02-28 University Of North Carolina At Chapel Hill, The Production of gonorrheal pi proteins and vaccines in e. coli and salmonella
US7252828B2 (en) 1998-07-15 2007-08-07 The Brigham And Women's Hospital, Inc. Polysaccharide vaccine for staphylococcal infections
JP4974414B2 (ja) * 1999-05-13 2012-07-11 ワイス・ホールディングズ・コーポレイション アジュバント混合製剤
US7585510B1 (en) * 1999-09-30 2009-09-08 Isis Innovation Limited Vaccine
CN1800385B (zh) * 2000-02-28 2010-06-02 启龙有限公司 奈瑟球菌蛋白质的异源表达
WO2002038177A2 (en) * 2000-11-10 2002-05-16 Wyeth Holdings Corporation Adjuvant combination formulations
US10919956B2 (en) 2002-11-12 2021-02-16 The Brigham And Women's Hospital, Inc. Polysaccharide vaccine for staphylococcal infections
US7723087B2 (en) 2002-11-12 2010-05-25 The Brigham And Women's Hospital, Inc. Nucleic acid molecules for enhanced production of a bacterial polysaccharide and methods of use thereof
PL1745075T3 (pl) 2004-04-21 2013-09-30 Brigham & Womens Hospital Inc Peptydy wiążące poli-N-acetyloglukozaminę (PNAG/DPNAG) i sposoby ich zastosowania
US7037698B2 (en) 2004-05-19 2006-05-02 Amano Enzyme Inc. Pyrroloquinoline quinone-dependent glucose dehydrogenase
KR20110031393A (ko) 2008-07-21 2011-03-25 더 브리검 앤드 우먼즈 하스피털, 인크. 합성 베타-1,6 글루코사민 올리고당에 관한 방법 및 조성물

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4237224A (en) * 1974-11-04 1980-12-02 Board Of Trustees Of The Leland Stanford Jr. University Process for producing biologically functional molecular chimeras
US4203971A (en) * 1978-03-23 1980-05-20 Government Of The United States Neisseria gonorrhoeae vaccine
DE2814039C3 (de) * 1978-03-31 1981-02-19 Gesellschaft Fuer Biotechnologische Forschung Mbh (Gbf), 3300 Braunschweig Verfahren zur Herstellung von Hybrid-Bakterien
US4351761A (en) * 1978-05-15 1982-09-28 Research Corporation Purified antigen to test for Neisseria gonorrhoeae antibodies
US4220638A (en) * 1978-10-12 1980-09-02 Merck & Co., Inc. Antigenic complex from N. Gonorrhoeae
US4288557A (en) * 1978-10-12 1981-09-08 Merck & Co., Inc. Antigenic complex from N. gonorrhoeae
US4239749A (en) * 1979-09-27 1980-12-16 United States Of America Neisseria gonorrhoeae vaccine
FI63596C (fi) * 1981-10-16 1983-07-11 Orion Yhtymae Oy Mikrobdiagnostiskt foerfarande som grundar sig pao skiktshybridisering av nukleinsyror och vid foerfarandet anvaenda kombinationer av reagenser
WO1983003354A1 (en) * 1982-03-30 1983-10-13 Us Army Neisseria gonorrhoeae vaccine
EP0178863A1 (en) * 1984-10-15 1986-04-23 Schering Corporation Novel expression systems utilizing bacteriophage T7 promoters and gene sequences
US4681761A (en) * 1985-10-24 1987-07-21 State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University Major iron-regulated protein of Neisseria gonorrhoeae and its use as vaccine
US4786592A (en) * 1986-06-18 1988-11-22 Scripps Clinic And Research Foundation Neisseria gonorrhoeae lectin useful as a vaccine and diagnostic marker and means for producing this lectin
CA1340506C (en) * 1987-11-24 1999-04-20 Nicholas H. Carbonetti Production of gonorrheal pi proteins and vaccines

Also Published As

Publication number Publication date
AU2795989A (en) 1989-06-14
US6068992A (en) 2000-05-30
JPH10234388A (ja) 1998-09-08
KR970011309B1 (ko) 1997-07-09
JP3388171B2 (ja) 2003-03-17
JP2803058B2 (ja) 1998-09-24
DK128490D0 (da) 1990-05-23
JPH03502881A (ja) 1991-07-04
FI102189B1 (fi) 1998-10-30
US5736361A (en) 1998-04-07
EP0395706A4 (en) 1991-11-13
NO902251L (no) 1990-07-18
FI902569A0 (fi) 1990-05-23
DK128490A (da) 1990-07-06
EP0395706B1 (en) 1998-08-19
CA1340506C (en) 1999-04-20
AU629807B2 (en) 1992-10-15
KR890701750A (ko) 1989-12-21
EP0869133A1 (en) 1998-10-07
DE3856240D1 (de) 1998-09-24
DK175831B1 (da) 2005-03-14
EP0395706A1 (en) 1990-11-07
NO302622B1 (no) 1998-03-30
DE3856240T2 (de) 1999-05-06
ATE169958T1 (de) 1998-09-15
FI102189B (fi) 1998-10-30
WO1989004873A1 (en) 1989-06-01

Similar Documents

Publication Publication Date Title
NO902251L (no) Fremstilling av gonoreiske p1-proteiner og vaksiner.
EP0192392A3 (en) Insulin receptor, its purification, its production in recombinant cells, dna therefor, antibodies to insulin receptor and their preparation, and pharmaceutical compositions containing them
EA199700244A1 (ru) Слитый белок, экспрессирующий вектор, рекомбинантный штамм, вакцинный препарат
ATE482714T1 (de) Modifizierter hitzeschockprotein-antigenpeptid- komplex
NO863000D0 (no) Fusjonsproteiner og fremgangsmaate til fremstilling derav.
DE262192T1 (de) Verfahren und mittel zur herstellung eines proteins mit dergleichen igg-spezifizitaet wie protein g.
ATE338113T1 (de) Transferrin-rezeptor gene von haemophilus
DK482788D0 (da) Vacciner mod og diagnostiske bestemmelser af haemophilus influenzae
DK0791063T3 (da) Bærerprotein med adjuvansvirkning, immunogent kompleks omfattende det, fremgangsmåde til fremstilling deraf, nukleotidsekvens og vaccine
ATE157258T1 (de) Zubereitungen und behandlungen von pneumonia in tieren
DE68923286T2 (de) Impfstoffe und testsätze für haemophilus influenzae.
DE69839848D1 (de) Nicht identische gene und ihre anwendung in verbesserten molekularen adjuvanten
SE8601940D0 (sv) Preparation of fused proteins, antibodies and processes therefor
DK0805204T3 (da) Bitestikel - specifikt receptorprotein og anvendelse heraf
DE69021886D1 (de) Äusseres membranprotein p1 und peptide von haemophilus influenzae typ b.
IL82720A0 (en) Recombinant polypeptide containing the amino acid sequence of the protein of feline leukemia virus,expression vehicles,plasmids coding for said protein,method for production thereof and pharmaceutical compositions
DK595187A (da) Minactivin og fremgangsmaade til fremstilling deraf
DE3889562T2 (de) Rekombinante Plasmide, die zur Expression von heterologen Proteinen in Bacillus verwendet werden können.
AU2001251410A1 (en) 12303, a novel human twik molecule and uses thereof